Allogene Therapeutics (ALLO) Q1 2025 Earnings

Mar 13Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-0.41
-0.37
-0.32
-0.28

Details

Expected EPS
-0.326522
Actual EPS
-0.28
Surprise EPS
0.05
Surprise Percent
+14.25%

Description

⁨Allogene Therapeutics⁩ (⁦ALLO⁩) has reported earnings of ⁦-0.28⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts